Authors: Warrier, I

Citation: I. Warrier, Thrombotic disorders in infancy and childhood, PEDIAT ANN, 30(9), 2001, pp. 558-563

Authors: Unuvar, A Warrier, I Lusher, JM

Citation: A. Unuvar et al., Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors, HAEMOPHILIA, 6(3), 2000, pp. 150-157

Authors: Jadhav, M Warrier, I

Citation: M. Jadhav et I. Warrier, Anaphylaxis in patients with hemophilia, SEM THROMB, 26(2), 2000, pp. 205

Authors: Thorland, EC Drost, JB Lusher, JM Warrier, I Shapiro, A Koerper, MA Dimichele, D Westman, J Key, NS Sommer, SS

Citation: Ec. Thorland et al., Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk, HAEMOPHILIA, 5(2), 1999, pp. 101-105

Authors: Warrier, I

Citation: I. Warrier, Factor IX antibody and immune tolerance, VOX SANGUIN, 77, 1999, pp. 70-71

Authors: Arkin, S Cooper, HA Hutter, JJ Miller, S Schmidt, ML Seibel, NL Shapiro, A Warrier, I

Citation: S. Arkin et al., Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program, HAEMOSTASIS, 28(2), 1998, pp. 93-98